RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 129 filers reported holding RIGEL PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 0.36 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $65 | -100.0% | 50,288 | -79.5% | 0.01% | -79.2% |
| Q2 2022 | $277,000 | +109.8% | 245,227 | +537.6% | 0.02% | +166.7% |
| Q1 2021 | $132,000 | +20.0% | 38,459 | -15.7% | 0.01% | -52.6% |
| Q3 2020 | $110,000 | +64.2% | 45,636 | +24.9% | 0.02% | +137.5% |
| Q2 2020 | $67,000 | 0.0% | 36,539 | +41.6% | 0.01% | +100.0% |
| Q2 2019 | $67,000 | +45.7% | 25,798 | +42.6% | 0.00% | +33.3% |
| Q1 2019 | $46,000 | -69.3% | 18,089 | -72.2% | 0.00% | -62.5% |
| Q4 2018 | $150,000 | -54.0% | 65,180 | -35.9% | 0.01% | -60.0% |
| Q3 2018 | $326,000 | – | 101,612 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 9,105,691 | $30,140,000 | 5.99% |
| Sio Capital Management, LLC | 1,888,181 | $6,250,000 | 3.50% |
| DAFNA Capital Management LLC | 473,478 | $1,567,000 | 1.32% |
| Cormorant Asset Management, LP | 2,000,000 | $6,620,000 | 0.96% |
| Ghost Tree Capital, LLC | 1,100,000 | $3,641,000 | 0.68% |
| Rhenman & Partners Asset Management AB | 1,282,000 | $4,243,000 | 0.67% |
| Palo Alto Investors LP | 4,254,623 | $14,083,000 | 0.67% |
| NEA Management Company, LLC | 3,243,150 | $10,375,000 | 0.36% |
| Telemetry Investments, L.L.C. | 170,000 | $563,000 | 0.25% |
| NJ State Employees Deferred Compensation Plan | 355,000 | $1,175,000 | 0.22% |